Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Biochimica Et Biophysica Acta
|
December 14, 2004
Structural insights into the regulatory mechanism of IP3 receptor
Ivan Bosanac, Takayuki Michikawa, Katsuhiko Mikoshiba, et al.
The Journal of Biological Chemistry
|
March 1, 2007
Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors
Miwako Iwai, Takayuki Michikawa, Ivan Bosanac, et al.
Molecular Cell
|
January 25, 2005
Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor
Ivan Bosanac, Haruka Yamazaki, Toru Matsu-Ura, et al.
The Journal of Biological Chemistry
|
September 9, 2005
Structural analysis of Mg2+ and Ca2+ binding to CaBP1, a neuron-specific regulator of calcium channels
Jennifer N Wingard, Jenny Chan, Ivan Bosanac, et al.
Journal of Molecular Biology
|
March 15, 2011
Modulation of K11-linkage formation by variable loop residues within UbcH5A
Ivan Bosanac, Lilian Phu, Borlan Pan, et al.
The Journal of Biological Chemistry
|
October 10, 2006
Structural characterization of a blue chromoprotein and its yellow mutant from the sea anemone Cnidopus japonicus
Mitchell C Y Chan, Satoshi Karasawa, Hideaki Mizuno, et al.
Journal of Molecular Biology
|
October 5, 2007
Ligand-induced conformational changes via flexible linkers in the amino-terminal region of the inositol 1,4,5-trisphosphate receptor
Jenny Chan, Andrew E Whitten, Cy M Jeffries, et al.
Nature Structural & Molecular Biology
|
June 30, 2009
The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling
Ivan Bosanac, Henry R Maun, Suzie J Scales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer
Aparna R Parikh, Fa-Chyi Lee, Linda Yau, et al.
Journal of Cancer Research and Clinical Oncology
|
April 13, 2018
MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach
Hans-Joachim Schmoll, Dirk Arnold, Aimery de Gramont, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Biochimica Et Biophysica Acta
|
December 14, 2004
Structural insights into the regulatory mechanism of IP3 receptor
Ivan Bosanac, Takayuki Michikawa, Katsuhiko Mikoshiba, et al.
The Journal of Biological Chemistry
|
March 1, 2007
Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors
Miwako Iwai, Takayuki Michikawa, Ivan Bosanac, et al.
Molecular Cell
|
January 25, 2005
Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor
Ivan Bosanac, Haruka Yamazaki, Toru Matsu-Ura, et al.
The Journal of Biological Chemistry
|
September 9, 2005
Structural analysis of Mg2+ and Ca2+ binding to CaBP1, a neuron-specific regulator of calcium channels
Jennifer N Wingard, Jenny Chan, Ivan Bosanac, et al.
Journal of Molecular Biology
|
March 15, 2011
Modulation of K11-linkage formation by variable loop residues within UbcH5A
Ivan Bosanac, Lilian Phu, Borlan Pan, et al.
The Journal of Biological Chemistry
|
October 10, 2006
Structural characterization of a blue chromoprotein and its yellow mutant from the sea anemone Cnidopus japonicus
Mitchell C Y Chan, Satoshi Karasawa, Hideaki Mizuno, et al.
Journal of Molecular Biology
|
October 5, 2007
Ligand-induced conformational changes via flexible linkers in the amino-terminal region of the inositol 1,4,5-trisphosphate receptor
Jenny Chan, Andrew E Whitten, Cy M Jeffries, et al.
Nature Structural & Molecular Biology
|
June 30, 2009
The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling
Ivan Bosanac, Henry R Maun, Suzie J Scales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer
Aparna R Parikh, Fa-Chyi Lee, Linda Yau, et al.
Journal of Cancer Research and Clinical Oncology
|
April 13, 2018
MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach
Hans-Joachim Schmoll, Dirk Arnold, Aimery de Gramont, et al.
Page
of 2